{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:52:11Z","timestamp":1792511531443,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>First recognized in children in the United States, Lyme borreliosis (LB) is the most prevalent tickborne illness in North America and Europe. However, the incidence of LB in children, including geographic variation and difference from that in adults, is incompletely described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We compiled surveillance data from public health agency websites reporting age-stratified LB case data, which was combined with census data to derive incidence estimates. Additional incidence estimates were obtained through a systematic literature review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 18 surveillance systems and 15 published studies for derivation of LB incidence in children. National incidence of &gt;10 cases in children per 100,000 per year were estimated for the United States and parts of Eastern, Western and Northern Europe. However, there was substantial variation in incidence among countries in some European regions. National incidence estimates from the literature largely aligned with estimates from surveillance. Surveillance-reported pediatric incidence was lower than adult incidence in adults in 8 countries, similar to adult incidence in 3 countries, and higher than adult incidence in 1 country. Among all pediatric age strata, the 5\u20139 years of age stratum had the highest proportion of pediatric cases in most countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>As pediatric LB represents a substantial proportion of overall LB incidence across countries in Europe and North America, LB prevention and control efforts should target pediatric as well as adult populations. However, better data are needed to fully characterize the difference in incidence across geographic regions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004040","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T20:01:14Z","timestamp":1688587274000},"page":"867-874","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The Incidence of Lyme Borreliosis Among Children"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0083-9379","authenticated-orcid":false,"given":"Madiha","family":"Shafquat","sequence":"first","affiliation":[{"name":"Vaccines, Antivirals, and Evidence Generation, Medical Affairs, Pfizer Biopharma Group, Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick J.","family":"Angulo","sequence":"additional","affiliation":[{"name":"Vaccines, Antivirals, and Evidence Generation, Medical Affairs, Pfizer Biopharma Group, Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pilz","sequence":"additional","affiliation":[{"name":"Vaccines, Antivirals, and Evidence Generation, Medical Affairs, Pfizer Biopharma Group, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Mo\u00efsi","sequence":"additional","affiliation":[{"name":"Vaccines, Antivirals, and Evidence Generation, Medical Affairs, Pfizer Biopharma Group, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Stark","sequence":"additional","affiliation":[{"name":"Vaccines, Antivirals, and Evidence Generation, Medical Affairs, Pfizer Biopharma Group, Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities.","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-86-6-685","article-title":"Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.","volume":"86","author":"Steere","year":"1977","journal-title":"Ann Intern Med"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"730","DOI":"10.7326\/0003-4819-91-5-730","article-title":"Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini.","volume":"91","author":"Steere","year":"1979","journal-title":"Ann Intern Med"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease-a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3201\/eid2708.204763","article-title":"Comparison of Lyme disease in the United States and Europe.","volume":"27","author":"Marques","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/0128071-200809060-00002","article-title":"Skin manifestations of Lyme borreliosis.","volume":"9","author":"M\u00fcllegger","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/INF.0000000000001653","article-title":"Neuroborreliosis in Swedish children: a population-based study on incidence and clinical characteristics.","volume":"36","author":"Sodermark","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","article-title":"Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.","volume":"27","author":"Skogman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1542\/peds.2011-3719","article-title":"Long-term clinical outcome after Lyme neuroborreliosis in childhood.","volume":"130","author":"Skogman","year":"2012","journal-title":"Pediatrics"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365540802593453","article-title":"Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe.","volume":"41","author":"Oymar","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/archdischild-2011-300526","article-title":"Lyme meningitis, the major cause of childhood meningitis in an endemic area: a population based study.","volume":"97","author":"Tveitnes","year":"2012","journal-title":"Arch Dis Child"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease.","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/vbz.2022.0071","article-title":"Incidence of Lyme borreliosis in Europe from national surveillance systems (2005\u20132020).","volume":"23","author":"Burn","year":"2023","journal-title":"Vector Borne Zoonotic Dis"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/vbz.2022.0070","article-title":"Incidence of Lyme borreliosis in Europe: a systematic review (2005-2020).","volume":"23","author":"Burn","year":"2023","journal-title":"Vector Borne Zoonotic Dis"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005-2010.","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3201\/eid2702.202728","article-title":"Use of commercial claims data for evaluating trends in Lyme disease diagnoses, United States, 2010-2018.","volume":"27","author":"Schwartz","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3390\/jcm9082324","article-title":"Etiology, clinical presentation and incidence of infectious meningitis and encephalitis in Polish children.","volume":"9","author":"Toczylowski","year":"2020","journal-title":"J Clin Med"},{"key":"R24-20250614","first-page":"76","article-title":"Importance of acaricide treatment for prevention of natural focal infections of tick-borne encephalitis and Lyme borreliosis in St. Petersburg.","volume":"12","author":"Bogachkina","year":"2011","journal-title":"EpiNorth"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12223-011-0036-y","article-title":"Lyme borreliosis--analysis of the trends in Slovakia, 1999-2008.","volume":"56","author":"Svihrova","year":"2011","journal-title":"Folia Microbiol (Praha)"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"101549","DOI":"10.1016\/j.ttbdis.2020.101549","article-title":"Changes in Lyme neuroborreliosis incidence in Denmark, 1996 to 2015.","volume":"11","author":"Tetens","year":"2020","journal-title":"Ticks Tick Borne Dis"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"21184","DOI":"10.2807\/1560-7917.ES2015.20.28.21184","article-title":"Improving national surveillance of Lyme neuroborreliosis in Denmark through electronic reporting of specific antibody index testing from 2010 to 2012.","volume":"20","author":"Dessau","year":"2015","journal-title":"Euro Surveill"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/MAO.0b013e318289844c","article-title":"Microbiologic findings in acute facial palsy in children.","volume":"34","author":"Kanerva","year":"2013","journal-title":"Otol Neurotol"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10096-020-04064-7","article-title":"The clinical presentation, treatment and outcome of serologically confirmed paediatric Lyme disease in the Republic of Ireland over a 5-year period: a retrospective cohort study.","volume":"40","author":"Forde","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10096-006-0167-2","article-title":"Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers.","volume":"25","author":"Bennet","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"e0265765","DOI":"10.1371\/journal.pone.0265765","article-title":"Incidence of Lyme disease in the United Kingdom and association with fatigue: a population-based, historical cohort study.","volume":"17","author":"Brellier","year":"2022","journal-title":"PLoS One"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.anpedi.2015.07.008","article-title":"Enfermedad de Lyme en edad pedi\u00e1trica.","volume":"84","author":"V\u00e1zquez-L\u00f3pez","year":"2016","journal-title":"Anales de Pediatr\u00eda"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ttbdis.2014.09.004","article-title":"Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis.","volume":"6","author":"Lohr","year":"2015","journal-title":"Ticks Tick Borne Dis"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.puhe.2023.03.002","article-title":"Estimated number of symptomatic Lyme borreliosis cases in Germany in 2021 after adjusting for under-ascertainment.","volume":"219","author":"Olsen","year":"2023","journal-title":"Public Health"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/vbz.2022.0051","article-title":"Estimated number of symptomatic Lyme borreliosis cases in adults in finland in 2021 using seroprevalence data to adjust the number of surveillance-reported cases: a general framework for accounting for underascertainment by public health surveillance.","volume":"23","author":"Olsen","year":"2023","journal-title":"Vector Borne Zoonotic Dis"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"ofz299","DOI":"10.1093\/ofid\/ofz299","article-title":"Misdiagnosis of Lyme disease with unnecessary antimicrobial treatment characterizes patients referred to an academic infectious diseases clinic.","volume":"6","author":"Kobayashi","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.cmi.2019.02.020","article-title":"Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study.","volume":"25","author":"Webber","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.","volume":"128","author":"Reid","year":"1998","journal-title":"Ann Intern Med"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/318138","article-title":"Death from inappropriate therapy for Lyme disease.","volume":"31","author":"Patel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"607","DOI":"10.15585\/mmwr.mm6623a3","article-title":"Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease - United States.","volume":"66","author":"Marzec","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(18)31738-0","article-title":"Introducing EU-wide surveillance of Lyme neuroborreliosis.","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3201\/eid2812.212612","article-title":"Systematic review and meta-analysis of Lyme disease data and seropositivity for Borrelia burgdorferi, China, 2005","volume":"28","author":"Stark","year":"2022","journal-title":"Emerg Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:05:03Z","timestamp":1749945903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004040","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,3]]}}}